Tech Company M&A Transactions
bioTheranostics Acquisition
bioTheranostics, operating out of San Diego, was acquired by Hologic. Deal value was $230 million.
Transaction Overview
Company Name
Acquired By
Announced On
1/6/2021
Transaction Type
M&A
Amount
$230,000,000
M&A Terms
Acquiring Biotheranostics enables us to jump-start our entry into a large, fast-growing oncology adjacency that fits perfectly with our broader corporate focus and passion for women's health.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
9640 Towne Centre Dr. 200
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
BioTheranostics, Inc. is a commercial-stage molecular diagnostics company that develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Donald Hardison
Chief Financial Officer
Gail Sloan
Chief Medical Officer
Miriam Bloch
Chief Scientific Officer
Catherine Schnabel
VP - Marketing
Debbie Ledet
VP - Operations
Debra Hadley
VP - Sales
Matt Sargent
Browse more venture capital transactions:
Prev: 1/6/2021: Yesler venture capital transaction
Next: 1/6/2021: Caveonix venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs